Discure Technologies Announces $16 Million in Financing Led by BOLD Capital Partners, Supernova Invest and Sanara Capital
Funds will advance the clinical testing of Discure’s breakthrough device for degenerative disc disease PETACH-TIKVA, Israel, Sept. 10, 2024 /PRNewswire/ — Discure Technologies Ltd., developer of the Discure System, a bioelectronic implantable device for the treatment of degenerative disc disease... Read More →
GenNext and Agilent Unveil Groundbreaking Technology Integration to Accelerate High-Value Decision Making in Biopharmaceutical Research
Half Moon Bay, CA – September 10, 2024 – Today at CASSSS 2024, GenNext Technologies and Agilent announced a pioneering collaboration that promises to transform structural biology research for biopharmaceutical companies. The integration of GenNext’s AutoFox Protein Footprinting System with... Read More →
EpiCypher Expands Exclusive Licensing Agreement to Advance CUT&Tag Technology
DURHAM, N.C., Sept. 4, 2024 /PRNewswire/ — EpiCypher®, a trailblazer in epigenetic research technologies, is pleased to announce an exclusive licensing agreement with Fred Hutch Cancer Center. This agreement grants EpiCypher access to pivotal intellectual property (IP) related to CUT&Tag... Read More →
Renata Medical Receives FDA Approval for the Minima Growth Stent, First-of-its-Kind Device for Treating Aortic Coarctation and Pulmonary Artery Stenosis
NEWPORT BEACH, Calif.–(BUSINESS WIRE)–Renata Medical today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s first-of-its-kind Minima Growth Stent that’s specifically tailored for neonates, infants, and young children, but also designed to be re-expanded over the... Read More →
Vitestro Achieves CE Marking for Autonomous Blood Drawing Device
UTRECHT, Netherlands, Aug. 28, 2024 /PRNewswire/ — Vitestro, a pioneer in the field of medical robotics, is proud to announce that its innovative automated blood drawing device has received CE marking. This marks a significant milestone for the company, acknowledging... Read More →
Two New FDA-Clearances for Sibel Health Enables Compatibility of Advanced Wearable Sensors to 3rd Party Software Solutions
CHICAGO, Aug. 22, 2024 /PRNewswire/ — Sibel Health announces two additional FDA-clearances enabling its advanced wearable sensors to operate with compatible third party software applications. In order to democratize vital signs globally, Sibel Health is committed to enabling widespread access... Read More →
Universal DX Initiates Clinical Trial for FDA Approval of Signal-C® Colorectal Cancer Screening Blood Test
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Universal DX (“UDX”), a biotech company dedicated to transforming cancer into a curable disease by detecting it early, today announced closure of the Series B which funds the clinical trial for its colorectal cancer screening blood test, Signal-C®,... Read More →
Precision oncology startup 4baseCare raises $6 million in funding
4baseCare, a Bengaluru-based healthcare startup focused on precision oncology, has raised $6 million in a Series A funding round led by Yali Capital, with participation from other investors. The startup will use the raised capital to enhance its product offerings... Read More →
CRISPR QC Launches Three Innovative Products and Unveils Revamped Website
SAN DIEGO–(BUSINESS WIRE)–CRISPR QC, a pioneering biotechnology company in San Diego, is excited to announce the launch of several groundbreaking products designed to revolutionize the field of gene editing. These products, part of the CRISPR Analytics Platform, provide comprehensive insights... Read More →
PanTher Therapeutics Receives FDA Clearance of IND Application for Phase 1b Study of PTM-101 for the Localized Treatment of Pancreatic Cancer
AUSTIN, Texas–(BUSINESS WIRE)–PanTher Therapeutics (“PanTher” or the “Company”), a clinical-stage oncology company redefining cancer treatment with therapeutics administered continuously and exclusively at the tumor site, today announced the U.S. Food and Drug Administration (FDA) clearance of the Investigational New Drug... Read More →